PDGF expression supports the tumoral development of GBM, while the amplification of PDGFRα significantly promotes tumor aggressive behavior and is correlated to ATRX loss, leading to further research regarding therapeutic target opportunities in this field [54,131]. The gene discussed is PDGFRA; the disease is glioblastoma.